Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Eczematous

Explore clinical trials studying Skin Diseases, Eczematous. Study availability and eligibility vary by location and protocol.

1,455 public trials 170 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Eczematous trial results

Completed

A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis

NCT05383378

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • selectION Clinical Trial Site Berlin, Germany
  • selectION Clinical Trial Site Hamburg, Germany
  • selectION Clinical Trial Site Magdeburg, Germany
  • selectION Clinical Trial Site Mainz, Germany
View Trial Details
Completed

HPA Axis Study in Adults

NCT01408511

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • PAREXEL Bloemfontein Bloemfontein, South Africa
  • PAREXEL George George, South Africa
  • PAREXEL Port Elizabeth Port Elizabeth, South Africa
View Trial Details
Completed

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

NCT05014438

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Local Institution - 0091 Fremont, California, United States
  • Local Institution - 0112 Brandon, Florida, United States
  • Local Institution - 0061 Coral Gables, Florida, United States
  • Local Institution - 0110 Margate, Florida, United States
View all 42 locations
View Trial Details
Completed

Open-label Study of Dupilumab in Patients With Atopic Dermatitis

NCT01949311

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Regeneron Study Site Anniston, Alabama, United States
  • Regeneron Study Site Birmingham, Alabama, United States
  • Regeneron Study Site 1 Birmingham, Alabama, United States
  • Regeneron Study Site 2 Birmingham, Alabama, United States
View all 432 locations
View Trial Details
Completed

A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

NCT04626297

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clinical Research Center of Alabama- Birmingham Birmingham, Alabama, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Orange County Research Institute Anaheim, California, United States
View all 85 locations
View Trial Details

Related conditions